MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Association of UV radiation with Parkinson’s disease incidence: A nationwide French ecologic study

    A. Elbaz, K. Sofiane, L. Wald, A. Dugravot, A. Singh-Manoux, F. Moisan, A. Kravietz (Villejuif, France)

    Objective: Using ultraviolet B (UV-B) as a surrogate for vitamin D levels, we conducted a nationwide ecologic study in France in order to examine the…
  • 2016 International Congress

    Evaluation of the [ 99mTc] – TRODAT- 1 SPECT in the diagnosis of Parkinson’s disease and other movement disorders

    G. Fabiani, R. Martins Filho, H.A.G. Teive (Campina Grande do Sul, Brazil)

    Objective: Evaluation of the [ 99mTc] - TRODAT- 1 SPECT in the diagnosis of PD and other MD. Create a DATA bank for our population.…
  • 2016 International Congress

    Parkinson’s disease and the frequent reasons for emergency admission in Metropolitan Medical Center; a 2 year retrospective study

    C.L. Go, K.A. Wong (Manila, Philippines)

    Objective: To determine the frequent cause of hospitalization among adult patients with Parkinson's disease (PD) in our institution. Background: Parkinson's disease is the second most…
  • 2016 International Congress

    Life expectancy and dementia – Two sides of the coin in Parkinson’s disease

    S. Tursunov, G. Rakhimbaeva, F. Yunusov, K. Abdukhalimova, R. Agzamov, R. Mirzaev, D. Lutfullaeva, J. Olimov (Tashkent, Uzbekistan)

    Objective: Our primary aim was to evaluate whether Parkinson's disease is associated with an increased risk of dementia and death. Background: The prevalence of Parkinson's…
  • 2016 International Congress

    The association between objectively measured physical activity and health-related-quality of life in people with Parkinson’s disease

    J.M.T. Van Uem, I. Liepelt-Scarfone, B. Cerff, M. Kampmeyer, J. Prinzen, M. Zuidema, M.A. Hobert, S. Hucker, S. Del Din, S. Gräber, D. Berg, W. Maetzler (Tübingen, Germany)

    Objective: To evaluate the association between a large number of objectively measured parameters of physical activity in the domestic environment using wearable sensors and Health-Related-Quality…
  • 2016 International Congress

    Objective decrement in Parkinson’s disease – A new parameter for the BRAIN tap test

    H. Hasan, D.S. Athauda, T. Foltynie, G. Giovannoni, T. Warner, A.J. Lees, A. Noyce (East Riffa, Bahrain)

    Objective: To evaluate a new parameter – Bradykinesia Index (BI) as an new objective measure within the BRAIN (BRadykinesia Akinesia INcoordination) tap test. Background: The…
  • 2016 International Congress

    The method of biofeedback training for the patients with Parkinson’s disease

    I.S. Goursky, S.A. Likhachev, V.V. Vashchylin (Minsk, Belarus)

    Objective: The objective of the research was to develop a biofeedback training method for the patients with Parkinson's disease (PD), utilizing videomotion analysis for the…
  • 2016 International Congress

    Myoclonus Dystonia: A report of two rare mutations

    A. Mahajan, C. Sidiropoulos (Detroit, MI, USA)

    Objective: To present the results of genetic analysis of three patients who presented to our clinic with Myoclonus Dystonia. Background: Myoclonus Dystonia (MD) is a…
  • 2016 International Congress

    SLC6A17 mutations are not a common cause of intellectual disability and movement disorders in a large cohort of consanguineous Iranian families

    I.A. Meijer, L.J. Azcona, H. Darvish, C. Paisán-Ruiz (New York, NY, USA)

    Objective: To determine the prevalence of SLC6A17 mutations in a cohort of Iranian patients with intellectual disability and movement disorders. Background: Mutations in the SLC6A17…
  • 2016 International Congress

    Phenotypic characteristics in GBA-associated Parkinson’s disease (PD): A study in a Greek population

    A.M. Simitsi, C. Koros, N. Papagiannakis, R. Antonelou, M. Moraitou, H. Michelakakis, M. Stamelou, L. Stefanis (Athens, Greece)

    Objective: To evaluate whether there are distinct motor and non-motor symptom characteristics in GBA-associated PD (GBA-PD) in a Greek population. Background: Mutations in the GBA1…
  • « Previous Page
  • 1
  • …
  • 157
  • 158
  • 159
  • 160
  • 161
  • …
  • 207
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Patients with Essential Tremor Live Longer than their Relatives
  • #23624 (not found)
  • The hardest symptoms that bother patients with Parkinson's disease
  • Three cases of early tremor in the course of Guillain-Barré Syndrome
  • The impact of gastric acid suppressants and antacids on levodopa plasma concentration in patients with Parkinson’s disease
  • To be or not to bupropion: a drug-induced parkinsonism?
  • The Role of MRI and DaTscan in Vascular Parkinsonism: A Case Report
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley